当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析

华兰生物

(002007)

  

流通市值:227.80亿  总市值:264.62亿
流通股本:15.73亿   总股本:18.27亿

华兰生物(002007)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.43亿元,每股收益0.13元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1363358.88万元,未分配利润761052.63万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1505877.77万元,负债142518.89万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入762,111,441.694,595,017,702.013,378,886,377.051,798,197,926.21
营业总成本545,394,537.653,373,662,053.192,486,370,142.961,310,025,664.46
其他经营收益
营业利润298,558,400.341,228,542,093.211,008,099,521.47635,103,212.79
利润总额289,500,377.361,173,348,364.31972,414,239.42611,444,107.03
净利润242,594,496.21999,992,847.58827,700,992.33522,691,390.04
每股收益
其他综合收益----
综合收益总额242,594,496.21999,992,847.58827,700,992.33522,691,390.04
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计8,702,943,388.958,859,302,029.210,048,714,890.019,336,064,233.9
非流动资产:
非流动资产合计6,355,834,301.216,402,964,684.566,218,654,717.556,199,376,166.61
资产总计15,058,777,690.1615,262,266,713.7616,267,369,607.5615,535,440,400.51
流动负债:
流动负债合计1,324,172,152.181,795,309,181.382,926,029,063.111,465,892,254.06
非流动负债:
非流动负债合计101,016,767.1275,963,257.7391,743,064.7799,244,269.77
负债合计1,425,188,919.31,871,272,439.113,017,772,127.881,565,136,523.83
所有者权益(或股东权益):
归属于母公司股东权益合计11,720,324,917.3111,500,605,548.7311,371,869,789.6912,013,171,120.84
股东权益合计13,633,588,770.8613,390,994,274.6513,249,597,479.6813,970,303,876.68
负债和股东权益合计15,058,777,690.1615,262,266,713.7616,267,369,607.5615,535,440,400.51
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计882,873,232.124,517,254,586.113,106,028,325.262,049,433,728.88
经营活动现金流出小计889,262,811.553,639,298,085.862,655,399,510.671,818,926,770.1
经营活动产生的现金流量净额-6,389,579.43877,956,500.25450,628,814.59230,506,958.78
投资活动产生的现金流量:
投资活动现金流入小计2,678,651,192.7812,491,605,975.979,673,231,639.897,502,570,348.64
投资活动现金流出小计2,114,713,943.7511,957,323,173.778,936,858,346.826,994,719,593.08
投资活动产生的现金流量净额563,937,249.03534,282,802.2736,373,293.07507,850,755.56
筹资活动产生的现金流量:
筹资活动现金流入小计-724,942,840.01724,405,900.01278,159,999.98
筹资活动现金流出小计447,000,0002,722,005,980.661,583,602,566.451,220,104,824.1
筹资活动产生的现金流量净额-447,000,000-1,997,063,140.65-859,196,666.44-941,944,824.12
汇率变动对现金及现金等价物的影响-80,561.38140,062.36175,338.16189,692.01
现金及现金等价物净增加额110,467,108.22-584,683,775.84327,980,779.38-203,397,417.77
期末现金及现金等价物余额884,043,554.06773,576,445.841,686,241,001.061,154,862,803.91
补充资料:
现金及现金等价物的净增加额--584,683,775.84--203,397,417.77
最新报告期:2026-04-29
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
诚通证券李志新0.540.590.662026-04-29
中信证券陈竹,王凯旋0.520.570.642026-04-28
兴业证券东楠,孙媛媛,黄翰漾0.590.660.782026-04-20
中信建投汤然,刘若飞,贺菊颖0.500.570.622026-04-10
国投证券胡雨晴0.520.590.672026-04-03
TOP↑